Literature DB >> 25045118

Synthesis of bridged oxafenestranes from pleuromutilin.

Robert W Hicklin1, Tania L López Silva, Paul J Hergenrother.   

Abstract

Fenestranes are an intriguing class of highly strained molecules possessing a quaternary carbon with bonds that deviate from the canonical tetrahedral geometry. Herein we report the discovery that the natural product pleuromutilin can be used as a structurally complex starting material for the synthesis of a series of bridged cis,cis,cis,cis-[4.5.5.5]- and cis,cis,cis,cis-[4.5.7.5]oxafenestranes through a carbocation rearrangement cascade. X-ray crystallographic analysis of several cis,cis,cis,cis-[4.5.5.5]oxafenestranes shows a significant planarization of the central tetracoordinate carbon atom and demonstrates the influence of bridgehead substituents and bridging rings on planarity.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  fenestranes; natural products; planar tetracoordinate carbon atom; strained molecules

Mesh:

Substances:

Year:  2014        PMID: 25045118     DOI: 10.1002/anie.201404765

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  11 in total

1.  Re-engineering natural products to engage new biological targets.

Authors:  Stephen E Motika; Paul J Hergenrother
Journal:  Nat Prod Rep       Date:  2020-11-18       Impact factor: 13.423

2.  Predictive compound accumulation rules yield a broad-spectrum antibiotic.

Authors:  Michelle F Richter; Bryon S Drown; Andrew P Riley; Alfredo Garcia; Tomohiro Shirai; Riley L Svec; Paul J Hergenrother
Journal:  Nature       Date:  2017-05-10       Impact factor: 49.962

3.  Re-Engineering of Yohimbine's Biological Activity through Ring Distortion: Identification and Structure-Activity Relationships of a New Class of Antiplasmodial Agents.

Authors:  Nicholas G Paciaroni; David L Perry; Verrill M Norwood; Claribel Murillo-Solano; Jennifer Collins; Srinivasarao Tenneti; Debopam Chakrabarti; Robert W Huigens
Journal:  ACS Infect Dis       Date:  2020-01-16       Impact factor: 5.084

4.  A Tryptoline Ring-Distortion Strategy Leads to Complex and Diverse Biologically Active Molecules from the Indole Alkaloid Yohimbine.

Authors:  Nicholas G Paciaroni; Ranjala Ratnayake; James H Matthews; Verrill M Norwood; Austin C Arnold; Long H Dang; Hendrik Luesch; Robert W Huigens
Journal:  Chemistry       Date:  2017-02-03       Impact factor: 5.236

Review 5.  The challenge of converting Gram-positive-only compounds into broad-spectrum antibiotics.

Authors:  Michelle F Richter; Paul J Hergenrother
Journal:  Ann N Y Acad Sci       Date:  2018-02-15       Impact factor: 5.691

Review 6.  Facilitating Compound Entry as a Means to Discover Antibiotics for Gram-Negative Bacteria.

Authors:  Kristen A Muñoz; Paul J Hergenrother
Journal:  Acc Chem Res       Date:  2021-02-26       Impact factor: 22.384

Review 7.  Recent Progress in Natural-Product-Inspired Programs Aimed To Address Antibiotic Resistance and Tolerance.

Authors:  Yasmeen Abouelhassan; Aaron T Garrison; Hongfen Yang; Alejandra Chávez-Riveros; Gena M Burch; Robert W Huigens
Journal:  J Med Chem       Date:  2019-04-18       Impact factor: 7.446

8.  Access to a Structurally Complex Compound Collection via Ring Distortion of the Alkaloid Sinomenine.

Authors:  Alfredo Garcia; Bryon S Drown; Paul J Hergenrother
Journal:  Org Lett       Date:  2016-09-21       Impact factor: 6.005

9.  Limonin as a Starting Point for the Construction of Compounds with High Scaffold Diversity.

Authors:  Lucia Furiassi; Emily J Tonogai; Paul J Hergenrother
Journal:  Angew Chem Int Ed Engl       Date:  2021-06-10       Impact factor: 16.823

10.  Preventing Morphine-Seeking Behavior through the Re-Engineering of Vincamine's Biological Activity.

Authors:  Verrill M Norwood; Ariana C Brice-Tutt; Shainnel O Eans; Heather M Stacy; Guqin Shi; Ranjala Ratnayake; James R Rocca; Khalil A Abboud; Chenglong Li; Hendrik Luesch; Jay P McLaughlin; Robert W Huigens
Journal:  J Med Chem       Date:  2020-03-23       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.